Nephrosant
About:
NephroSant’s mission is to deliver new diagnostic tools for early detection and lifetime monitoring of kidney health and injury.
Website: https://nephrosant.com/
Twitter/X: nephrosant
Top Investors: DigitalDx Ventures, DaVita Venture Group
Description:
NephroSant is a fast-paced diagnostic startup founded by physicians, with a team of world-class scientists, engineers and clinicians, focused on applying the founding team's years of clinical research expertise to improve global kidney health.
Total Funding Amount:
$16M
Estimated Revenue Range:
$10M to $50M
Headquarters Location:
Brisbane, California, United States
Founded Date:
2017-01-01
Founders:
Joshua Yang, Minnie Sarwal
Number of Employees:
11-50
Last Funding Date:
2021-03-16
IPO Status:
Private
Industries:
© 2025 bioDAO.ai